HomePMCB • NASDAQ
Follow
Pharmacyte Biotech Inc
Previous close
$2.44
Day range
$2.42 - $2.49
Year range
$1.92 - $3.23
Market cap
20.91M USD
Avg Volume
37.62K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.87M | 20.35% |
Net income | -619.54K | 18.92% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 61.21M | -15.73% |
Total assets | 71.36M | -8.46% |
Total liabilities | 17.18M | 1,974.89% |
Total equity | 54.18M | — |
Shares outstanding | 8.46M | — |
Price to book | 0.66 | — |
Return on assets | -6.22% | — |
Return on capital | -8.07% | — |
Cash Flow
Net change in cash
(USD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -619.54K | 18.92% |
Cash from operations | -177.10K | 67.31% |
Cash from investing | -5.00M | — |
Cash from financing | -7.04M | -86.31% |
Net change in cash | -12.21M | -182.60% |
Free cash flow | 62.94K | 108.53% |
About
Founded
1996
Headquarters
Website
Employees
2